Herbas VPB

Print
EN | LT
LT - ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF
EN - ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395
A61K 47/48
A61P 35/00
C07K 16/30
C07K 19/00
C12N 1/21
C12N 15/13
C12N 15/63
C12N 5/10
G01N 33/574
G01N 33/577
European patent
(11) Number of the document 1827492
(13) Kind of document T
(96) European patent application number 05852645.0
Date of filing the European patent application 2005-11-30
(97) Date of publication of the European application 2007-09-05
(45) Date of publication and mention of the grant of the patent 2010-08-11
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2005/043482
Date 2005-11-30
PCT application publication
(87) Number WO 2006/071441
Date 2006-07-06
Priority applications
(30) Number Date Country code
632023 P 2004-11-30 US
733779 P 2005-11-07 US
Inventors
(72)
RASTELLI, Luca, US
POLLACK, Vincent, A., US
TSE, Kam, Fai, US
KLAKAMP, Scott, US
FOORD, Orit, US
LIANG, Meina, US
JIA, Xiao-Chi, US
XIAO, Feng, US
LICHENSTEN, Henri, US
HERRMANN, John, US
LAROCHELLE, William, J., US
JEFFERS, Michael, E., US
CHAPOVAL, Andrei, US
MEZES, Peter, US
ARA, Gulshan, US
TORGOV, Michael, US
KARKARIA, Cyrus, US
DAVAGNINO, Juan, US
Grantee
(73) Curagen Corporation, 322 East Main Street, Branford, CT 06405, US
Abgenix, Inc., 6701 Kaiser Drive, Fremont, CA 94555, US
Title
(54) ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF
  ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF